About this trial
Low blood sugar in newborns is common and if prolonged or untreated may place them at increased risk for later learning and behavior challenges. Currently, we measure newborn glucose with at least four painful heel sticks, missing one in four episodes of low blood sugar. The goal of this observational study is to develop a less invasive approach to glucose monitoring, developed for newborns, that provides more frequent glucose measurements. We will also measure how a pregnant woman's health impacts newborn glucose, and how newborn glucose is linked to brain oxygen saturation and development.
Eligibility criteria
Qualifiers
women aged 18 years or older
speaks English, Spanish, Portuguese, or Haitian Creole
pregnant >24 weeks gestation with singleton pregnancy
Disqualifiers
known concomitant maternal or fetal condition which, in the opinion of the investigator, could present a risk to the safety or welfare of the subject or study staff
plans to deliver at a hospital other than Women and Infants Hospital of Rhode Island
Trial design
Treatments tested in this trial
- Continuous glucose monitoring
- Cerebral near-infrared spectroscopy